China High Precision Automation Group (HPAGF) Fair Value & Analysis
Technology · US · Market cap $30.1M
Fair value as of: Jun 26, 2026
Analysis
China High Precision Automation Group (HPAGF) currently trades at $0.0290, while our model-based Fair Value estimate is $0.0296 — implying the stock looks roughly 1.9% undervalued today. We read business quality at 92/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: low) — always confirm before acting.
About the company
China High Precision Automation Group Limited, an investment holding company, manufactures and sells high precision industrial automation instrument and technology products in the People's Republic of China and internationally. It operates through two segments, Automation Instrument and Technology Products, and Horological Instruments. The company is involved in the manufacturing and selling of intelligent display instruments, flow accumulate instruments, pressure transmitters, and logging control instruments, as well as multi-functional all-plastic quartz watch movements; and provision of consigned processing services. It also offers temperature transmitter; instrument valves and tube fittings; and flowmeter. China High Precision Automation Group Limited was founded in 1991 and is headquartered in Wan Chai, Hong Kong.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is China High Precision Automation Group (HPAGF) undervalued?
What is the fair value of HPAGF?
What is the quality score of HPAGF?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.